Lindus Health Unveils Versatile All-in-One ‘Respiratory CRO’ Offering Suitable for Respiratory Clinical Trials

n n n ‘. concat(e. i18n. t(“search. voice. recognition_retry”),’n

NEW YORK, April 2, 2024 /PRNewswire/ — Lindus Health, the “anti-CRO” company powering radically faster and more reliable clinical trials for life sciences pioneers, has unveiled an all-in-one suite of contract study organizations (CROs). Services specially designed for clinical studies on respiratory diseases.

With the all-in-one respiratory CRO, breathing sponsors will gain advantages from a diversity of classic CRO expertise, in-depth knowledge of this area of healing, and access to Lindus Health’s number one network of care, consisting of more than 30 million electronic fitness devices. (EHR) and its custom in-house eClinical software, Citrus™.

Lindus Health has enrolled more than 6500 patients in respiratory clinical trials in the U. S. He has been in the US, UK, and Europe, demonstrating his extensive resume of experience in this area of healing. From start to finish, this offering covers end-to-end execution on many respiratory disease indications, adding asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, pneumonia, and many more.

“There are many nuances to conducting breath testing, ranging from overcoming demanding situations of subjective and vague measurements for some tests to the heterogeneity and variability of symptoms in those conditions,” said Luke Twelves, MD, Chief Medical Officer of Array at Lindus Health. “We are excited to launch a tailored CRO that enables respiratory disease sponsors to alleviate the demanding situations they face when bringing critical respiratory treatments to market.

Lindus Health is revered for being united through a notable advisory board with breathing expertise, joined by Bob Langer, co-founder of Moderna and professor at the MIT Institute, along with other famous experts in the field such as Professor Chris Butler, Peter Polos, MD, and Dr. David Stempel.

“Working with the Lindus Health team has been a game-changer,” said Akash Bijalani, Head of Global Market Access at Aptar, a global leader in respiratory medicine technologies and customer products. “They have an attitude and make things happen, going above and beyond the line of duty. “

Lindus Health’s complete all-in-one respiratory CRO solution offers the following to the respiratory market:

End-to-end CRO and trial management services: Lindus Health’s clinical operations team brings extensive expertise in each and every phase of respiratory research, covering everything from initial protocol design and patient recruitment to comprehensive data monitoring and delivery.

Global Recruiting Expertise: Lindus Health’s number one network of care, with more than 30 million electronic fitness records (EHRs), offers effective recruiting in addition to community and on-site methods and virtual marketing tactics. The company is bringing the trials to the right audience. Help respiratory disease sponsors meet their hiring goals faster.

Study-specific eClinical technology: Lindus Health’s evolved clinical trial software, Citrus™, ensures seamless integration of knowledge across all platforms needed for effective exam execution, adding electronic data capture (EDC), clinical trial management system (CTMS), electronic consent, and randomization. and much more.

On-site expert services: Lindus Health’s in-house on-site operations team has the perfect relationships with principal investigators (PIs) and others interested in on-site studies and is well-versed in active breathing studies of all types, at one or more sites, virtual/hybrid or traditional.

Extensive specific expertise in regulatory and therapeutic areas: Combining diverse study backgrounds, the Lindus Health team brings exceptional expertise in respiratory clinical trials and the ever-changing regulatory landscapes of the U. S. and Canada. U. S. , U. K. , and EU.

Lindus Health is committed to effectively leading breathing research, providing a physically powerful and effective framework for clinical trials, from start to finish, and controlling the experience of sponsors and participants.

To learn more about Lindus Health’s all-in-one respiratory CRO, click here.

About Lindus Health

Lindus Health is an anti-CRO that drives radically faster and more reliable assays for life sciences pioneers, bringing breakvia remedies to patients faster. Lindus Health achieves this through an incentive-aligned business style (fixed quotes consistent with the study, with step-by-step payments), which combines a world-class clinical team with its proprietary software platform and access to 30 million electronic fitness records. Clinical trials are the main barrier to progress in fitness care, and by removing this limitation, they target fitness in everything. They manage the end-to-end execution of clinical studies, adding design, patient recruitment, clinical knowledge entry, tracking, and assignment management.

To date, Lindus Health has conducted more than 90 trials in the U. S. and Canada. We have used the U. S. , U. K. , and Europe to address a variety of conditions, including diabetes, asthma, acne, social anxiety, primary depressive disorder, hypertension, chronic fatigue syndrome, and insomnia.

The company is named after James Lind, a pioneer in early clinical trials and treatments for scurvy, and was co-founded by Michael Young, a former special adviser to the British Prime Minister for Life Sciences, and Meri Beckwith, a former life sciences investor.

Lindus Health has raised more than $24 million from investors Peter Thiel, CREANDUM, First Minute Capital, Presight Capital, Seedcamp, Hambro Perks, Amino Collective, and Calm/Storm.

Media Contact: Jodi Perkins Amendola de Lindus Healthjperkins@acmarketingpr. com

Check out the content to download the multimedia: https://www. prnewswire. com/news-releases/lindus-health-unveils-versatile-all-in-one-respiratory-cro-offering-tailored-to-respiratory-clinical -essays -302105221. html

SOURCE Lindus Health

Leave a Comment

Your email address will not be published. Required fields are marked *